[1]
Wang, J.Y. et al. 2015. MHC class I-presented tumor antigen appraisable for T-cell responses against ovarian cancer.
Bangladesh Journal of Pharmacology
. 10, 3 (Jul. 2015), 524–528. DOI:https://doi.org/10.3329/bjp.v10i3.23076.